Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5‐[(4‐chloro/2, 4‐dichloro) benzylidene] thiazolidine‐2, 4 …

K El‐Adl, AGA El‐Helby, H Sakr, RR Ayyad… - Archiv der …, 2021 - Wiley Online Library
The anticancer activity of novel thiazolidine‐2, 4‐diones was evaluated against HepG2, HCT‐
116, and MCF‐7 cells. MCF‐7 was the most sensitive cell line to the cytotoxicity of the new …

Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2, 4-dichloro) benzylidene] thiazolidine-2, 4 …

K El-Adl, AGA El-Helby, H Sakr… - Archiv der …, 2021 - pubmed.ncbi.nlm.nih.gov
The anticancer activity of novel thiazolidine-2, 4-diones was evaluated against HepG2, HCT-
116, and MCF-7 cells. MCF-7 was the most sensitive cell line to the cytotoxicity of the new …

Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2, 4-dichloro) benzylidene] thiazolidine-2, 4 …

K El-Adl, AA El-Helby, H Sakr, RR Ayyad… - Archiv der …, 2020 - europepmc.org
The anticancer activity of novel thiazolidine-2, 4-diones was evaluated against HepG2, HCT-
116, and MCF-7 cells. MCF-7 was the most sensitive cell line to the cytotoxicity of the new …